Fig. 3
From: Increasing demand for ophthalmic pathology: time trends in a laboratory with nationwide coverage
Enucleations for uveal melanoma and retinoblastoma. A) In linear regression, enucleation became a less frequent primary treatment for uveal melanoma during the period (β = -0.8, R2 = 0.64, P < 0.0001). B) There was no significant trend for the number of children that underwent enucleation for retinoblastoma between 1998 and 2020 (β = -0.1, R2 = 0.07, P = 0.23)